Abstract:BACKGROUND:Genome-wide association studies (GWAS) have successfully identified genetic susceptible variants for complex diseases. However, the underlying mechanism of such association remains largely unknown. Most disease-associated genetic variants have been shown to reside in noncoding regions, leading to the hypothesis that regulation of gene expression may be the primary biological mechanism. Current methods to characterize gene expression mediating the effect of genetic variant on diseases, often analyzed one gene at a time and ignored the network structure. The impact of genetic variant can propagate to other genes along the links in the network, then to the final disease. There could be multiple pathways from the genetic variant to the final disease, with each having the chain structure since the first node is one specific SNP (Single Nucleotide Polymorphism) variant and the end is disease outcome. One key but inadequately addressed question is how to measure the between-node connection strength and rank the effects of such chain-type pathways, which can provide statistical evidence to give the priority of some pathways for potential drug development in a cost-effective manner.RESULTS:We first introduce the maximal correlation coefficient (MCC) to represent the between-node connection, and then integrate MCC with K shortest paths algorithm to rank and identify the potential pathways from genetic variant to disease. The pathway importance score (PIS) was further provided to quantify the importance of each pathway. We termed this method as "MCC-SP". Various simulations are conducted to illustrate MCC is a better measurement of the between-node connection strength than other quantities including Pearson correlation, Spearman correlation, distance correlation, mutual information, and maximal information coefficient. Finally, we applied MCC-SP to analyze one real dataset from the Religious Orders Study and the Memory and Aging Project, and successfully detected 2 typical pathways from APOE genotype to Alzheimer's disease (AD) through gene expression enriched in Alzheimer's disease pathway.CONCLUSIONS:MCC-SP has powerful and robust performance in identifying the pathway(s) from the genetic variant to the disease. The source code of MCC-SP is freely available at GitHub ( https://github.com/zhuyuchen95/ADnet ).

Detection for Gene-Gene Co-Association Via Kernel Canonical Correlation Analysis

Gene-Gene association for Imaging Genetics Data using Robust Kernel Canonical Correlation Analysis

Gene- or Region-Based Association Study Via Kernel Principal Component Analysis.

MCC-SP: a Powerful Integration Method for Identification of Causal Pathways from Genetic Variants to Complex Disease.

Testing Gene-Gene Interactions Based on a Neighborhood Perspective in Genome-wide Association Studies

Gene-centric gene-gene interaction: A model-based kernel machine method

Identifying complex gene–gene interactions: a mixed kernel omnibus testing approach

Genome-wide interaction-based association analysis identified multiple new susceptibility Loci for common diseases.

Inferring gene-gene interactions and functional modules using sparse canonical correlation analysis

Detecting Essential and Removable Interactions in Genome-Wide Association Studies

A fast algorithm for detecting gene-gene interactions in genome-wide association studies

BayesKAT: bayesian optimal kernel-based test for genetic association studies reveals joint genetic effects in complex diseases

GWGGI: software for genome-wide gene-gene interaction analysis

Regression-based Approach for Testing the Association Between Multi-Region Haplotype Configuration and Complex Trait

Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics

Detecting Local Genetic Correlations with Scan Statistics

Cloud Computing for Detecting High-Order Genome-Wide Epistatic Interaction Via Dynamic Clustering.

Ensemble learning for detecting gene-gene interactions in colorectal cancer

Searching Genome-Wide Multi-Locus Associations for Multiple Diseases Based on Bayesian Inference.

Genome-wide association studies with high-dimensional phenotypes